The transcribed-ultraconserved regions (T-UCRs) are a novel class of non-coding RNAs, which are absolutely conserved (100%) between the orthologous regions of the human, rat and mouse genomes. Previous studies have described that several T-UCRs show differential expressions in cancers and might be involved in cancer development. We investigated the transcriptional levels of representative 26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa) and gastric cancer (GC). A quantitative reverse transcription-polymerase chain reaction analysis revealed the downregulation of Uc.158+A expression by a DNA methylation-associated mechanism, which was restored by 5-Aza-dC (5-aza-2′-deoxycytidine) treatment. Bisulfite genomic sequencing using cell lines and tissue samples demonstrated cancer-specific CpG hypermethylation in both GC and PCa. However, Uc.416+A was only overexpressed in GC and we identified an miR-153 binding site in the possible regulatory region of Uc.416+A using online databases. Along with a forced expression or knockdown of miR-153 in MKN-74 GC cells, the transcriptional levels of Uc.416+A were significantly disturbed. A luciferase reporter gene assay supported the direct regulation of Uc.416+A expression by miR-153. Furthermore, Uc.416+A was associated with cell growth through the regulation of IGFBP6 (insulin-like growth factor-binding protein 6) in GC. These findings suggest an oncogenic role of Uc.416+A in GC, which suggests that our approach would provide new insights into functional studies of T-UCRs in cancer biology.
INTRODUCTION
The transcribed-ultraconserved regions (T-UCRs) are a novel class of non-coding RNAs, which are a subset of the conserved sequences that are located in both the intragenic and intergenic regions. 1 They are absolutely conserved (100%) between the orthologous regions of the human, rat and mouse genomes. 1 T-UCRs are expressed in normal tissues either ubiquitously or in a specific pattern, depending on the tissue with a similar manner as microRNAs (miRNAs). 2 It is therefore likely that T-UCRs are involved in human tumorigenesis or that they undergo the epigenetic and genetic defects that occur in miRNAs. 3 Accordingly, it has been hypothesized that T-UCRs could be candidate genes for cancer susceptibility because the transcriptional levels of several UCRs are deregulated in cancer. 4 At least 481 UCRs have been described. These produce 962 possible transcripts: one corresponding to the sense genomic sequence (named '+') and the other to the complementary sequence (named '+A'). Several lines of systematic analysis using microarrays have suggested that T-UCRs are altered at the transcription level in human tumorigenesis and that different types of human cancer can be distinguished according to their specific aberrant T-UCR profiles. [4] [5] [6] [7] [8] [9] It has been reported that several T-UCRs are deregulated in colorectal cancer, 4 leukemia 4 and hepatocellular carcinoma. 5 As for the regulation mechanisms that are involved in the transcription of T-UCRs, thus far, the aberrant expression of T-UCRs have been found to occur by altered interactions with miRNAs, 4 or by the hypermethylation of CpG island promoters. 10 Uc.241+A and Uc.283+A have CpGenriched sequences in the upstream of their coding regions and their expressions have been restored in LNCaP prostate cancer (PCa) cells by treatment with 5-aza-2′-deoxycytidine (5-Aza-dC). 6 In colorectal cancer and leukemia, the hypermethylation of CpG islands could inhibit the expression of three T-UCRs that have significant antisense complementarity with specific miRNAs. 4 There is an inverse correlation between T-UCRs and miRNAs, similar to the interactions between miRNA and mRNA. Also, it has been reported that Uc.283+A inhibits pri-miR-195 processing through direct RNA:RNA interaction. 11 However, there is less knowledge on the effects that the interactions between T-UCRs and miRNAs have on the molecular characteristics and signaltransduction pathways that are involved in the biological functions of cancer development.
In the present study, we focused on PCa, one of the most common adult malignancies among men in developed countries, and gastric cancer (GC), the most frequent malignant neoplasms in eastern Asia countries. Although we previously identified several genes and non-coding RNAs whose expression was upregulated or downregulated in GC, [12] [13] [14] [15] the role of T-UCRs in GC remains unclear. To address the involvement of T-UCRs in cancer, we determined the expression profile using a quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and examined these epigenetic properties. Furthermore, we also demonstrated the functional roles of T-UCRs involved in tumor growth and explored their downstream regulation.
RESULTS
The expression analysis of T-UCRs in PCa and GC We narrowed down the 962 T-UCR regions to 57 regions in which the expression in PCa tissue differed to that in non-neoplastic prostatic tissue, based on a report of a microarray analysis. 6 We then focused on 26 candidates that were downregulated in PCa tissue to explore the possible involvement of gene silencing in epigenetic regulation. To validate the possible association between these candidate genes and PCa, a qRT-PCR of these 26 T-UCRs was performed in 16 PCa tissue samples and 10 nonneoplastic prostate tissue samples (Supplementary Figure S1) . The mean expression level of each gene was calculated and the ratio of tumor/non-neoplastic prostate was determined. As shown in Figure 1a , 14 regions (Uc.73+, Uc.118+A, Uc.158+A, Uc.241+A, Uc.244+, Uc.249+, Uc.252+A, Uc.261+, Uc.282+, Uc.346+A, Uc.359+A, Uc.389+, Uc.390+ and Uc.416+A) were significantly downregulated in the cancer tissue. We also confirmed the expression levels of these 14 transcripts using PCa cell lines (LNCaP and DU145) and non-cancerous prostate tissue. These expression levels in both cell lines were downregulated compared with non-cancerous prostate tissue, almost undetectable ( Figure 1b) . To evaluate the consistent association of these T-UCRs in GC as well as PCa, a qRT-PCR was also performed in 20 cases using GC samples and the corresponding non-neoplastic gastric mucosa, and the ratio of tumor/non-neoplastic prostate was determined (Supplementary Figure S2) . Eight regions (Uc.118+A, Uc.158+A, Uc.244+, Uc.249+, Uc.252+A, Uc.261+, Uc.282+ and Uc.359+A) were found to be significantly downregulated in GC as well as PCa. In contrast, only Uc.416+A expression was significantly upregulated in GC tissue, which contradicted the PCa finding (Figure 1c and Supplementary Table S4 ). A qRT-PCR analysis using GC cell lines (MKN-45 and MKN-74) and non-cancerous gastric mucosa also demonstrated that Uc.416+A showed a significantly higher expression level compared with non-cancerous stomach sample ( Figure 1d) .
Next, we evaluated the expression levels of T-UCRs in PCa and GC cells that were treated with 5-Aza-dC to investigate whether these regions were suppressed by DNA methylation-related inactivation. We compared the expression of T-UCRs in three 5-Aza-dC treatment groups (0, 0.3 and 3 μM) (Figure 1e Figure S3) . Taken together with these results, three T-UCRs (Uc.158+A, Uc.241+A and Uc.346+A) were determined that were consistently restored by DNA demethylation in four cell lines. Among them, Uc.241+A had been already reported as one of the upregulated T-UCRs in response to the 5-Aza-dC treatment 6 and Uc.346+A was also listed up as one of the deregulated T-UCRs in leukemia. 4 Because its expression seemed to be regulated by DNA methylation both in PCa and GC, to the author's knowledge, its expression has never been mentioned in any cancer-related articles, we decided to focus on Uc.158+A.
DNA hypermethylation suppressed Uc.158+A expression To evaluate the extent of Uc.158+A methylation in PCa and GC, we searched for the presence of CpG islands upstream of Uc.158+A. As expected, we identified them~500 bp upstream of Uc.158+A (Figure 2a) .
We next performed bisulfite genomic sequencing and found dense DNA methylation upstream of Uc.158+A in LNCaP and DU145 cells (Figure 2b ). We also found the DNA hypermethylation of this region in PCa tissue samples and, to a lesser extent, in nonneoplastic prostatic tissue. In GC, cancer-specific DNA methylation was also shown in GC cell lines, as well as in GC tissue samples.
To investigate whether this region has promoter activity, we constructed a luciferase vector (158A_Luc) containing the CpG island upstream of Uc.158+A ( Figure 2c ). As the relatively higher expression of intrinsic Uc.158+A was found in MKN-1 and MKN-45 cells (Figure 2d ), the luciferase vector was transfected into these two cell lines. We performed a luciferase assay using three types of vector constructs: pGL3 basic vector, 158A_Luc and 158A_Luc vector treated by DNA methyltransferase (SssI methylase). The significant suppression of the reporter activity was found when the Uc.158+A upstream sequence was methylated (Figure 2e ). Thus, these results indicate that Uc.158+A expression is silenced by the DNA methylation of its promoter region.
Uc.416+A overexpression was associated with miR-153 downregulation in GC As shown in Figure 1 , the overexpression of Uc.416+A was observed in GC but not in PCa. Because the transcriptional level of Uc.416+A was not affected by DNA demethylation in three (LNCaP, MKN-45 and MKN-74) out of four cell lines ( Figure 1 and Supplementary Figure S3 ), there may be another regulatory mechanism for this region. To verify the possibility of another regulatory mechanism, we further explored the interaction between Uc.416+A and miRNAs.
Using two online databases (UCbase (http://www.dsb.unimo.it/ UCbase/) and miRbase (http://www.mirbase.org/)), we identified that miR-153 and miR-4641 have sequences that are complementary to Uc.416+A (Figure 3a) . We focused on miR-153 and performed qRT-PCR analyses using GC tissue samples and noticed a significant downregulation of miR-153 in GC tissue in comparison with the tissue of the corresponding non-neoplastic gastric mucosa (P = 0.0017; Figure 3b ). On the other hand, Uc.416 +A was significantly upregulated in GC tissue compared with the tissue of the corresponding non-neoplastic gastric mucosa (P o 0.0001; Figure 3c ). This downregulation of miR-153 was inversely correlated with Uc.416+A expression (r = − 0.3834; Figure 3d ). We examined the effects of miR-153 to Uc.416+A in GC cells to determine the miRNA-associated regulation. We first performed qRT-PCR using three GC cell lines (MKN-1, MKN-45 and MKN-74). A higher expression of Uc.416+A was detected in MKN-45 and MKN-74 in comparison with MKN-1 cells (Figure 3e) . Meanwhile, we found that miR-153 expression in MKN-1 was apparently higher compared with that in MKN-45 and MKN-74 cells (Figure 3f ). This result supported the inverse correlation between Uc.416+A and miR-153. To further investigate this interaction, we used MKN-74 cells from a model with miR-153 forced expression and MKN-1 cells from a model of miR-153 knockdown. As expected, we observed the downregulation of Uc.416+A by the upregulation of miR-153 (Figure 3g) , and the upregulation of Uc.416+A by miR-153 knockdown (Figure 3h ). These results suggest that Uc.416+A expression might be influenced within the presence of miR-153. We next examined whether miR-153 could directly regulate Uc.416+A expression. We constructed a luciferase vector (416A_Luc) containing the sequence of Uc.416+A just beyond the stop codon of luciferase sequence (Figure 3i ). We transfected 416A_Luc vector and pGL3 control vector into the MKN-45 or MKN-74 cell lines and assessed the reporter activities. When miR-153 was co-transfected with 416A_Luc vector, the reporter activity was significantly reduced, indicating the direct interaction with Uc.416+A and miR-153 (Figure 3j ). These results show that Uc.416+A was upregulated in GC because of the removal of its inhibition by miR-153. In contrast, Uc.416+A was downregulated in LNCaP cells because of the overexpression of miR-153 (Supplementary Figure S4) . Taken together, we can conclude that Uc.416+A expression is directly regulated by miR-153 in GC and PCa.
Uc.416+A acts as an oncogene and is associated with cell proliferation in GC Although several lines of papers have reported the importance of some of the T-UCRs in cancer biology, there are no reports on Uc.416+A. To elucidate the characteristics of Uc.416+A, we examined the biological role of Uc.416+A in GC. We performed in situ hybridization of Uc.416+A and found that the expression of Uc.416+A was detected in the cytoplasm of GC cells (Figure 4a and Supplementary Figure S5a) . We investigated the effects of its downregulation using small interfering RNA (siRNA) that was designed to specifically target Uc.416+A. We observed a significantly lower expression of Uc.416+A at 48 h after treatment with two different siRNAs (Figure 4b ). Following these results, we carried out a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay at 4 days after the knockdown of Uc.416+A (Figure 4c ). The growth of MKN-74 cells was found to be significantly suppressed by Uc.416+A knockdown in comparison with MKN-74 cells that were treated with a negative control (P o 0.05). The same result was also found in MKN-45 cells (Supplementary Figures S5b and c) . These results indicate that Uc.416+A participates in cell proliferation in GC and that it has an important role as an oncogene.
To determine the putative targets of Uc.416+A, we carried out a global gene analysis using Affimetrix GeneChips. When comparing siRNA-transfected MKN-74 cells to negative control, numerous genes were found to be dysregulated. Among them, the most upregulated gene was IGFBP1 (insulin-like growth factor-binding protein 1) and the most downregulated was the ADH1C gene ( Table 1 ). In addition, we found that Uc.416+A knockdown also upregulated IGFBP6 and downregulated HOXB5 (homeobox 5) and HOXB6, which was located upstream or downstream of Uc.416+A.
We focused on these genes and performed a qRT-PCR and observed the consistent regulation through Uc.416+A knockdown (Figure 4d and Supplementary Figure S5d) . Next, we performed a qRT-PCR using GC tissue and found that IGFBP6 was significantly downregulated and HOXB5 and HOXB6 were upregulated in GC tissue in comparison with the corresponding non-neoplastic gastric mucosa (Figure 4e) . These results suggest that Uc.416+A promotes cell proliferation partially through the inhibition of IGFBP6. 
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DISCUSSION
In this study, we investigated T-UCRs whose expressions were deregulated in PCa and GC. We showed the downregulation of Uc.158+A in PCa and GC through the hypermethylation of its promoter region, which supports that some T-UCRs could be silenced by DNA methylation-associated regulation, much like silencing the expression of miRNAs. In addition, there might be hypermethylation of the CpG island in the other regions that had been upregulated by 5-Aza-dC treatment. Based on the results of this present study, it is presumed that there are a small number of variations in the localization of the coding region of T-UCRs on the DNA sequence. By using NCBI (http://www.ncbi.nlm.nih.gov/) to identify CpG islands in the DNA sequences, we actually found T-UCRs, such as Uc.160+, Uc.283+A and Uc.346+A, which are involved in DNA hypermethylation and which have CpG islands upstream of these regions. Similarly, when we observed miRNAassociated T-UCRs, such as Uc.215+, Uc.269+A and Uc.348+, we found that there were no distinct CpG dinucleotides around the sequences. These findings suggest that each pattern of localization could have specific mechanisms that are involved in the regulation of its expression, and that aberrant DNA methylation could be one of those major regulation mechanisms.
From in vitro studies, such as luciferase reporter gene assay and forced expression of miR-153, we showed the direct interaction between Uc.416+A and miR-153. A qRT-PCR analysis using GC tissues clearly displayed an inverse correlation between Uc.416+A and miR-153, which indicated an interaction between Uc.416+A and miR-153 in vivo. As found in the cell growth assay, Uc.416+A is presumed to act as an oncogene because the silencing of Uc.416 +A significantly reduced cell growth in GC. Combining these findings, we can conclude that miR-153 could act as a tumorsuppressive miRNA through the regulation of Uc.416+A, which might have oncogenic functions. Previously, several reports showed that miR-153 was downregulated in human glioblastoma, 16 oral cancer, 17 lung cancer 18 and ovarian cancer. 19 Furthermore, miR-153 was also downregulated in GC and its expression has a significant impact on the prognosis of GC patients. 20 In contrast, miR-153 was upregulated in colorectal cancer 21 and PCa, 22 which supported its oncogenic roles. Thus, whether miR-153 works as an oncogene or a tumor suppressor in cancers is still controversial. To clarify the importance of miR-153 in cancer biology, it is vital to determine the expression pattern of miR-153 in several types of cancer and to see whether there is interaction between miR-153 and Uc.416+A in all types of cancer.
From the microarray analysis, we also found that IGFBP1 and IGFBP6 were upregulated by Uc.416+A knockdown. IGFBPs are six specific proteins that are encoded by IGFBP1-6 and that bind to IGF-I and IGF-II with high affinity and act as a key regulator of IGF actions. 23 All of the IGFBPs have been shown to inhibit IGF activity because IGFBPs bind IGFs with higher affinity compared with IGF receptors preventing receptor bindings. 24 IGFBP6 is a relatively specific inhibitor of the actions of IGF-II, including IGF-II-induced proliferation differentiation, migration and survival in many cell lines. 25 In cancers, IGFBP6 expression is lower in malignant cells compared with that in normal cells, 26 suggesting that it has an inhibitory effect in cancer cells. These findings support our present results, which show that Uc.416+A knockdown upregulated IGFBP6 and reduced cell proliferation. We also showed that Uc.416+A knockdown downregulated the transcriptional levels of HOXB5 and HOXB6. The HOX gene family has an important role in the normal development of the human organs. 27 It is also associated with human diseases including cancers. HOXB5 is involved in normal lung and gut development 28, 29 and is also associated with malignant neoplasms such as breast cancer, 30 ovarian cancer 31 and bladder cancer. 32 HOXB6 is involved in the hematopoiesis and overexpressed acute myeloid leukemia. 33 Because T-UCRs frequently locate in the HOX gene clusters, our results suggest that Uc.416+A could cooperate with HOXB5 and HOXB6 to be involved in GC development.
A number of miRNA target-prediction databases have been developed and used for the functional analysis of miRNAs. However, the target genes listed by existing computational algorithms largely cover protein-coding genes, and do not cover non-coding genes. Although we were not able to detect the functional targets of miR-153 involved in cell proliferation using an online target-prediction database, our present study revealed that Uc.416+A was directly regulated by miR-153 and associated with cell growth through the upregulation of IGFBP6. These findings call for more studies on the interactions between T-UCRs and miRNAs in cancer biology.
In summary, we showed that the expression of Uc.158+A was silenced by DNA methylation of its promoter regions both in PCa and GC. We also identified that miR-153 directly regulates Uc.416 +A expression, which could contribute to GC cell proliferation through the regulation of its target genes. The findings in this present study provide evidence for an important role of T-UCR in cancer biology, and indicate that there are still unknown T-UCRs regulated by miRNAs that are also involved in oncogenic process of cancer. Our approach would be instrumental in picking out T-UCRs that have a crucial role in cancer biology.
MATERIALS AND METHODS
Cell lines and drug treatment
Two PCa cell lines (LNCaP and DU145) were purchased from the American Type Culture Collection (Manassas, VA, USA). Three GC cell lines of the MKN series were purchased from the Japanese Collection of Research Bioresources Cell Bank (Osaka, Japan). All cell lines were maintained in RPMI-1640 (Nissui Pharmaceutical Co. Ltd, Tokyo, Japan) containing 10% fetal bovine serum (BioWhittaker, Walkersville, MD, USA), 2 mM L-glutamine, 50 U/ml penicillin and 50 μg/ml streptomycin in a humidified atmosphere of 5% CO 2 and 95% air at 37°C. Cells were treated with a final Tables S1 and S2 ). The non-cancerous tissue samples were also obtained at biopsy or autopsy case, as described previously. 34 The samples were frozen immediately in liquid nitrogen and stored at − 80°C until use. The samples were randomly selected from patients who had undergone surgery at Hiroshima University Hospital or an affiliated hospital through the years 2005-2008. Comprehensive approvals for basic or clinical research were obtained from all of the patients. This was in accordance with the Ethical Guidance for Human Genome/Gene Research of the Japanese Government.
qRT-PCR analysis Total RNA was isolated from frozen samples or cancer cell lines using Isogen (Nippon Gene, Tokyo, Japan) and 1 μg of total RNA was converted to cDNA with a First Strand cDNA Synthesis Kit (Amersham Biosciences Corp., Piscataway, NJ, USA). The qPCR was performed with an SYBR Select Master Mix (Applied Biosystems, Austin, TX, USA). The primer sequences for the detection of each T-UCR are described in Supplementary Table S3 . Real-time detection of the emission intensity of SYBR green bound to double-stranded DNA was performed with a CFX Connect Real-Time System (Bio-Rad Laboratories, Hercules, CA, USA). ACTB-specific PCR products, which were amplified from the same RNA samples, served as internal controls. To quantify the level of miRNAs, TaqMan assays were performed as described previously. 35 The expression values were normalized to the expression of the small RNA gene RNU48 and the relative quantification was determined using the ΔΔCq method as described previously. 36 Genomic DNA extraction and bisulfite genomic DNA sequencing Genomic DNAs were extracted with a Genomic DNA Purification Kit (Promega, Madison, WI, USA). To examine DNA methylation patterns, genomic DNAs were treated with 3 M sodium bisulfite as described previously. 37 For the analysis of the DNA methylation of Uc.158+A, we performed a bisulfite genomic sequencing analysis. To obtain products for the sequencing, a PCR was performed, in each 50 μl reaction containing 0.2 μM dNTPs, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2 mM MgCl 2 , 0.3 μM primers and 0.75 U of AmpliTaq Gold (Applied Biosystems). The primer sequences were as follows: 5′-GGGAGAGAGGTGAGGGTTTAG-3′ and 5′-ACTCCAACCAAAAACCCCTC-3′. PCR products were purified and cloned into pCR2.1 (Invitrogen, Carlsbad, CA, USA). Individual cloned fragments were sequenced using an ABI PRISM 310 Genetic Analyzer (Applied Biosystems) as described previously. 38 
Transient transfection and luciferase assays
The genomic sequence of Uc.158+A upstream was cloned into the pGL3 basic vector (Promega) using its multicloning site (158A_Luc). The genomic sequence of Uc.416+A was also cloned into the pGL3 control vector using the XbaI site immediately downstream from the stop codon of luciferase (416A_Luc). Each construct was transfected into 1.0 × 10 4 of MKN-1, MKN-45 or MKN-74 cells in a 6-well culture dish with FuGENE6 (Roche Diagnostics, Indianapolis, IN, USA), according to the manufacturer's instructions. After 48 h, cells were harvested using a Dual Luciferase Reporter Assay Kit (Promega) and luciferase activity was measured using a GloMax luminometer (Promega).
In vitro methylation assay
In vitro methylation assays were carried out according to the methods described previously. Briefly, 1 μg of plasmid DNA containing Uc.158+A promoter construct was incubated 2 h with 2 U of SssI methylase (New England BioLabs, Ipswich, UK). After phenol extraction and ethanol precipitation, equal amounts (400 ng) of methylated or unmethylated reporter constructs were transiently transfected into MKN-1 or MKN-45 cells. The luciferase activities were examined as described above.
In situ hybridization For visualization of Uc.416+A, in situ hybridization of Uc.416+A was performed as described previously. 39 Briefly, the biotin 3′-labeled locked nucleic acid-incorporated probe (Custom LNA mRNA detection probe, Exiqon, Woburn, MA, USA) was used. The sequence of LNA probe was 5′-TGCTATGTATGCGGCCAAAT-3′. The formalin-fixed, paraffin-embedded cell clot samples (MKN-45 and MKN-74) were sectioned, deparaffinized and rehydrated. Sample slides were treated with proteinase K (Dako Cytomation, Carpinteria, CA, USA) for 20 min. A 20 nM probe was hybridized with the 1x Enzo in situ hybridization buffer (Exiqon). The samples slides were heated to 60°C for 5 min and incubated at 37°C for 14 h. Immunological detection was performed using the Dako GenPoint Tyramide Signal Amplification System for Biotin-labeled Probes (Dako Cytomation). The sections were then exposed to a streptavidin-peroxidase reaction and developed with DAB.
RNA interference and cell growth assay
Silencer Select (Ambion, Austin, TX, USA) against uc.416+A was used for RNA interference. Three independent oligonucleotides and negative control siRNA (Invitrogen) were used. The sequence of siRNA no. 1 was 5′-GCAUCGCUAUAAUUCAUUATT-3′, that of siRNA no. 2 was 5′-GCAUACAUAGCAAAACGAATT-3′. A total of 1.0 × 10 6 cells of MKN-74 or MKN-45 were plated on a 10-cm culture dish 24 h before transfection. Transfection was performed using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions. Cells were used 48 h after transfection in each of the experiments and assays.
To examine cell growth, an MTT assay was performed as described previously. 40 Cell growth was monitored after 1, 2 and 4 days.
Statistical analysis
All experiments were repeated at least three times with each sample in triplicate. Statistical analyses were conducted primarily using GraphPad Prism software (GraphPad Software Inc., San Diego, CA, USA). Statistical differences were evaluated using two-tailed Student's t-test or MannWhitney U-test. The results are expressed as the mean ± s.d. of triplicate measurements. Sample sizes for relevant experiments were determined by power analysis.
